| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
539 |
521 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
87 |
84 |
$9K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
183 |
183 |
$8K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
42 |
41 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
197 |
193 |
$5K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
32 |
30 |
$5K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
315 |
315 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
158 |
156 |
$2K |
| 90461 |
|
29 |
29 |
$1K |
| 96127 |
|
67 |
67 |
$759.98 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
17 |
16 |
$526.15 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$146.52 |